Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

N-9 Condom Safety GAO Evaluation Requested By Reps. Coburn, Pitts

This article was originally published in The Tan Sheet

Executive Summary

Republican Reps. Tom Coburn (Okla.) and Joseph Pitts (Penn.) have requested a General Accounting Office investigation into the potential harm caused by federal distribution of condoms with nonoxynol-9 microbicide.
Advertisement

Related Content

Latex Condom Labels Would Bear N-9, STD Warnings Under FDA Proposal
Latex Condom Labels Would Bear N-9, STD Warnings Under FDA Proposal
Latex Condom Labels Would Bear N-9, STD Warnings Under FDA Proposal
Nonoxynol-9 Messages Conveyed By HHS Agencies Inconsistent – GAO Report
Nonoxynol-9 Messages Conveyed By HHS Agencies Inconsistent – GAO Report
Nonoxynol-9 Messages Conveyed By HHS Agencies Inconsistent – GAO Report
UNAIDS N-9 Data Under WHO, Industry Analyses
N-9 Study Results Lead CDC To Reevaluate HIV Prevention Guidelines
Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results
Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results

Topics

Advertisement
UsernamePublicRestriction

Register

PS091637

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel